10.03.2026

Alithea Bio: Featured in smartXhealth Startup Spotlight

ALITHEA BIO SMARTX

Alithea Bio: AI Meets Immunotherapy

Startup Spotlight: smartXhealth Newsletter

Alithea Biotechnology GmbH

We develop data-driven solutions for modern immunotherapies. By combining Immunopeptidomics, Mass Spectrometry, and AI-based Bioinformatics, we identify therapeutic targets with high precision.

Our cloud-based HLA-peptide database helps predict the efficacy and safety of new therapies early, reducing preclinical risks and shortening development cycles.

Alithea Bio Team

Trinationale Innovationskraft

Featured by smartXhealth and supported by BadenCampus, we are proud to represent the Freiburg start-up scene.

The recent BioCampus Upper Rhine Investor Day in Basel highlighted the growing importance of our trinationale innovation space. Explore the BioCampus Platform for more details.

Join us for smartXhealth connect in May 2026.


Contact smartXhealth Today

Read more

5 Key Advancements in Cervical Carcinoma Research via the HLA-Compass Database

Read
Alithea Biotechnology is pleased to announce our participation in the German Biotech Days

Alithea Biotechnology is pleased to announce our participation in the German Biotech Days (Deutsche Biotechnologietage), taking place on April 22–23 in Leipzig.

Read
Alithea Bio joins Berlin's precision medicine ecosystem

Alithea Bio joins Berlin’s precision medicine ecosystem

Read